Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-04EMA Authorised: Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop) (irbesartan;hydrochlorothiazide) — sanofi-aventis groupe
Authorised fixed-dose combination of irbesartan and hydrochlorothiazide for hypertension in the EU.
-
EMA approval · 2026-07-27EMA Authorised: Irbesartan Zentiva (previously Irbesartan Winthrop) (irbesartan) — Zentiva k.s.
The EMA has authorised Irbesartan Zentiva, a Reformulated/renamed irbesartan product for hypertension, under Zentiva k.s. as the marketing a…
-
EMA approval · 2026-07-27EMA Authorised: Macitentan AccordPharma (macitentan) — Accord Healthcare
Macitentan AccordPharma has been authorized for use, with the therapeutic areas listed as hypertension and pulmonary disease.
-
EMA approval · 2026-07-21EMA Authorised: Tolucombi (telmisartan;hydrochlorothiazide) — Krka, d.d., Novo mesto
Authorised combination medicine Tolucombi (telmisartan and hydrochlorothiazide) for hypertension by Krka, d.d., Novo mesto.
-
EMA approval · 2026-07-08EMA Authorised: Tolura (telmisartan) — Krka, d.d., Novo mesto
Tolura (telmisartan) has been authorised in the EU for hypertension by Krka, d.d., Novo mesto.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-07-07EMA Authorised: Telmisartan Actavis (telmisartan) — Actavis Group PTC ehf
Telmisartan Actavis has been authorised for the treatment of hypertension in the EU.
-
EMA approval · 2026-06-12EMA Authorised: Amlodipine / Valsartan Mylan (amlodipine besilate;valsartan) — Mylan Pharmaceuticals Limited
Amlodipine besilate/valsartan combination (Amlodipine besilate; valsartan) by Mylan Pharmaceuticals Limited has been authorised for hyperte…
-
EMA approval · 2026-06-11EMA Authorised: Winrevair — Merck Sharp & Dohme B.V.
Winrevair has been authorised by EMA, with therapeutic area listed as Hypertension and Pulmonary; orphan medicine designation.
-
EMA approval · 2026-04-28EMA Authorised: Micardis (telmisartan) — Boehringer Ingelheim International GmbH
Micardis (telmisartan) has been authorised for use in Europe by Boehringer Ingelheim International GmbH for hypertension.
-
EMA approval · 2026-04-28EMA Authorised: MicardisPlus (telmisartan;hydrochlorothiazide) — Boehringer Ingelheim International GmbH
MicardisPlus (telmisartan and hydrochlorothiazide) has been authorised by the EMA for hypertension.
-
FDA approval · 2026-04-23FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application to market a fixed-dose combination tablet of olmesartan medoxomil and hydrochlorothiazide for th…
-
EMA approval · 2026-04-22EMA Authorised: Irbesartan Zentiva (previously Irbesartan Winthrop) (irbesartan) — Zentiva k.s.
The EMA authorised Irbesartan Zentiva for hypertension. It is a generic irbesartan product manufactured by Zentiva k.s.
-
FDA approval · 2026-04-21FDA Approved: VALSARTAN — Original Application (Laurus Labs Limited)
FDA approved Laurus Labs Limited's original application for VALSARTAN (valsartan) as a generic product.
-
EMA approval · 2026-04-17EMA Authorised: Micardis (telmisartan) — Boehringer Ingelheim International GmbH
The EMA authorised Micardis (telmisartan) by Boehringer Ingelheim International GmbH for use in hypertension, with a decision dated 18 Febru…
-
FDA approval · 2026-04-10FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for diltiazem hydrochloride from ScieGen Pharmaceuticals, Inc.
-
FDA approval · 2026-03-26FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for labetalol hydrochloride submitted by NorthStar Rx LLC.
-
EMA approval · 2026-03-06EMA Authorised: MicardisPlus (telmisartan;hydrochlorothiazide) — Boehringer Ingelheim International GmbH
EMA authorised MicardisPlus (telmisartan with hydrochlorothiazide) by Boehringer Ingelheim International GmbH for the treatment of hypertens…
-
FDA approval · 2026-03-05FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for the generic irbesartan/hydrochlorothiazide combination from Solco Healthcare US, LLC. The approv…
-
FDA approval · 2026-03-05FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for IRBESARTAN AND HYDROCHLOROTHIAZIDE (Teva) under ANDA077369.
-
EMA approval · 2026-03-02EMA Authorised: Rasilez (aliskiren) — Lxo Ireland Designated Activity Company
The EMA has authorised Rasilez (aliskiren) for the treatment of hypertension; the marketing authorisation holder is Lxo Ireland Designated A…
-
EMA approval · 2026-02-27EMA Authorised: Jeraygo (aprocitentan) — Idorsia Pharmaceuticals Deutschland GmbH
The EMA authorised Jeraygo (aprocitentan) for the treatment of hypertension. Idorsia Pharmaceuticals Deutschland GmbH is the marketing autho…
-
FDA approval · 2026-02-27FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original abbreviated new drug application for diltiazem hydrochloride from Macleods Pharmaceuticals Limited.
-
FDA approval · 2026-02-23FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)
The FDA approved a supplemental application for diltiazem hydrochloride from Zydus Pharmaceuticals USA Inc., approving a generic product.
-
FDA approval · 2026-02-18FDA Approved: ARBLI — Supplemental Application (Scienture LLC)
FDA approved a supplemental application for ARBLI (losartan potassium) filed by Scienture LLC.
-
FDA approval · 2026-02-17FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approves a supplemental application for Losartan Potassium and Hydrochlorothiazide from Macleods Pharmaceuticals Limited.